Plus Therapeutics stockholders elect all six director nominees and ratify auditor at 2024 annual meeting

PLUS THERAPEUTICS, INC.

All six director nominees elected: Clowes, van Es-Johansson, Hawkins, Hedrick, Lenk, Petersen. Votes For ranged 1.16M-1.18M.
Ratification of BDO USA as auditor for FY2024 approved: 2.43M For, 44,854 Against.
Advisory say-on-pay approved: 1.12M For, 163,917 Against.
Fourth amendment and restatement of 2020 Stock Incentive Plan approved: 1.10M For, 182,432 Against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.